GW Henssler & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.3M | Buy |
21,482
+1,122
| +6% | +$589K | 0.6% | 69 |
|
2025
Q1 | $12.9M | Buy |
20,360
+2,543
| +14% | +$1.61M | 0.74% | 59 |
|
2024
Q4 | $18.7M | Sell |
17,817
-251
| -1% | -$264K | 1.07% | 41 |
|
2024
Q3 | $19M | Sell |
18,068
-477
| -3% | -$501K | 1.07% | 41 |
|
2024
Q2 | $19.5M | Sell |
18,545
-908
| -5% | -$954K | 1.17% | 38 |
|
2024
Q1 | $18.7M | Sell |
19,453
-498
| -2% | -$479K | 1.1% | 42 |
|
2023
Q4 | $17.5M | Sell |
19,951
-528
| -3% | -$464K | 1.16% | 39 |
|
2023
Q3 | $16.9M | Sell |
20,479
-425
| -2% | -$350K | 1.15% | 38 |
|
2023
Q2 | $15M | Sell |
20,904
-198
| -0.9% | -$142K | 0.99% | 48 |
|
2023
Q1 | $17.3M | Sell |
21,102
-190
| -0.9% | -$156K | 1.15% | 42 |
|
2022
Q4 | $15.4M | Buy |
21,292
+410
| +2% | +$296K | 1.08% | 40 |
|
2022
Q3 | $14.4M | Buy |
20,882
+411
| +2% | +$283K | 1.08% | 41 |
|
2022
Q2 | $12.1M | Buy |
20,471
+55
| +0.3% | +$32.5K | 0.9% | 49 |
|
2022
Q1 | $14.3M | Buy |
20,416
+370
| +2% | +$258K | 0.87% | 50 |
|
2021
Q4 | $12.7M | Buy |
20,046
+134
| +0.7% | +$84.6K | 0.81% | 55 |
|
2021
Q3 | $12.1M | Buy |
19,912
+60
| +0.3% | +$36.3K | 0.84% | 55 |
|
2021
Q2 | $11.1M | Buy |
19,852
+490
| +3% | +$274K | 0.73% | 61 |
|
2021
Q1 | $9.16M | Buy |
19,362
+883
| +5% | +$418K | 0.66% | 63 |
|
2020
Q4 | $8.93M | Sell |
18,479
-1,799
| -9% | -$869K | 0.68% | 58 |
|
2020
Q3 | $11.4M | Sell |
20,278
-13,744
| -40% | -$7.69M | 0.96% | 50 |
|
2020
Q2 | $21.2M | Sell |
34,022
-2,916
| -8% | -$1.82M | 1.87% | 10 |
|
2020
Q1 | $18M | Sell |
36,938
-1,018
| -3% | -$497K | 1.83% | 12 |
|
2019
Q4 | $14.3M | Buy |
37,956
+1,835
| +5% | +$689K | 1.18% | 32 |
|
2019
Q3 | $10M | Buy |
36,121
+8,382
| +30% | +$2.33M | 0.89% | 47 |
|
2019
Q2 | $8.68M | Buy |
+27,739
| New | +$8.68M | 0.79% | 55 |
|